267 related articles for article (PubMed ID: 31747788)
1. Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins.
Loya J; Zhang C; Cox E; Achrol AS; Kesari S
CNS Oncol; 2019 Nov; 8(3):CNS38. PubMed ID: 31747788
[TBL] [Abstract][Full Text] [Related]
2. Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy.
Loya J; Zhang C; Cox E; Achrol AS; Kesari S
CNS Oncol; 2019 Nov; 8(3):CNS40. PubMed ID: 31747784
[TBL] [Abstract][Full Text] [Related]
3. A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas.
Zhang Y; Sun X; Huang M; Ke Y; Wang J; Liu X
Drug Des Devel Ther; 2015; 9():2947-59. PubMed ID: 26089644
[TBL] [Abstract][Full Text] [Related]
4. Convection-enhanced delivery in clinical trials.
Hall WA; Rustamzadeh E; Asher AL
Neurosurg Focus; 2003 Feb; 14(2):e2. PubMed ID: 15727423
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral chemotherapy.
Walter KA; Tamargo RJ; Olivi A; Burger PC; Brem H
Neurosurgery; 1995 Dec; 37(6):1128-45. PubMed ID: 8584154
[TBL] [Abstract][Full Text] [Related]
6. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
7. Locoregional infusion of IL13Rα2-specific immunotoxins in children and adults with high-grade glioma.
Rechberger JS; Daniels DJ
Ther Deliv; 2022 Aug; 13(8):385-389. PubMed ID: 35872639
[No Abstract] [Full Text] [Related]
8. Novel chemotherapeutics and other therapies for treating high-grade glioma.
Kang JH; Adamson C
Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
[TBL] [Abstract][Full Text] [Related]
9. Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies.
Kunwar S
Acta Neurochir Suppl; 2003; 88():105-11. PubMed ID: 14531568
[TBL] [Abstract][Full Text] [Related]
10. Molecular targeting of malignant glioma cells with an EphA2-specific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells.
Sun XL; Xu ZM; Ke YQ; Hu CC; Wang SY; Ling GQ; Yan ZJ; Liu YJ; Song ZH; Jiang XD; Xu RX
Cancer Lett; 2011 Dec; 312(2):168-77. PubMed ID: 21924825
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for low-grade gliomas.
Reddy AT; Packer RJ
Childs Nerv Syst; 1999 Oct; 15(10):506-13. PubMed ID: 10550582
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxins directed at interleukin-4 receptors as therapy for human brain tumors.
Puri RK
Methods Mol Biol; 2001; 166():155-76. PubMed ID: 11217365
[No Abstract] [Full Text] [Related]
14. Role of tyrosine kinase inhibitors in the management of high-grade gliomas.
Ahluwalia MS; Patel M; Peereboom DM
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1739-48. PubMed ID: 22050023
[TBL] [Abstract][Full Text] [Related]
15. Interstitial chemotherapy of experimental gliomas.
Zeller WJ; Bauer S; Remmele T; Wowra B; Sturm V; Stricker H
Cancer Treat Rev; 1990 Sep; 17(2-3):183-9. PubMed ID: 2272032
[TBL] [Abstract][Full Text] [Related]
16. Malignant Intracranial High Grade Glioma and Current Treatment Strategy.
Zhang X; Zhang W; Mao XG; Cao WD; Zhen HN; Hu SJ
Curr Cancer Drug Targets; 2019; 19(2):101-108. PubMed ID: 29848277
[TBL] [Abstract][Full Text] [Related]
17. Immunotoxin treatment of brain tumors.
Hall WA
Methods Mol Biol; 2001; 166():139-54. PubMed ID: 11217364
[No Abstract] [Full Text] [Related]
18. Intratumoral microinfusion of nimustine (ACNU) for recurrent glioma.
Wakabayashi T; Yoshida J; Mizuno M; Kajita Y
Brain Tumor Pathol; 2001; 18(1):23-8. PubMed ID: 11517970
[TBL] [Abstract][Full Text] [Related]
19. Editors' remarks: Evolving concepts for local therapies for glioma.
Westphal M; Tonn JC
Acta Neurochir Suppl; 2003; 88():VII-IX. PubMed ID: 14531552
[No Abstract] [Full Text] [Related]
20. Current and future directions for Phase II trials in high-grade glioma.
Alexander BM; Lee EQ; Reardon DA; Wen PY
Expert Rev Neurother; 2013 Apr; 13(4):369-87. PubMed ID: 23545053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
